Evidence map›Paper›PMID 21127698›Full record

ArticleVascular health and risk management2010

Prognostic value of changes in arterial stiffness in men with coronary artery disease.

Iana A Orlova, Eradzh Yu Nuraliev, Elena B Yarovaya, Fail T Ageev

Registry-linked trialAbstract read
In one paragraph

Article in Vascular health and risk management, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03309618 (Improving Arterial Wall Characteristics in Patients After Myocardial Infarction With a Very Low Dose of Fluvastatin and Valsartan), which is not on this map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03309618 nacompletedstarted 2012, after this paper: background citation

Improving Arterial Wall Characteristics in Patients After Myocardial Infarction With a Very Low Dose of Fluvastatin and Valsartan: Proof-of-concept Study

Ran2012Enrolled36Registered outcomes10Posted comparisons0ConditionsMyocardial InfarctionArmslow-dose combination of fluvastatin (10 mg) and valsartan (20 mg) (low-flu/val), Placebo
Open the trial in the graph
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. I Luso-Brazilian Positioning on Central Arterial Pressure.Arquivos brasileiros de cardiologia · 2017
    Guideline
  2. Guideline
  3. Trial
  4. Trial
  5. Article
  6. Brazilian Guidelines of Hypertension - 2020.Arquivos brasileiros de cardiologia · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Arterial distensibility in patients with ruptured and unruptured intracranial aneurysms: is it a predisposing factor for rupture risk?Medical science monitor : international medical journal of experimental and clinical research · 2013
    Article
  15. Article
  16. Role of genetic changes in the progression of cardiovascular diseases.International journal of biomedical science : IJBS · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Iana A OrlovaOutpatient Department, Russian Cardiology Research Center, Moscow, Russian Federation. orlova@cardio.ru
Eradzh Yu Nuraliev
Elena B Yarovaya
Fail T Ageev

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMen with coronary artery disease (CAD) have been shown to have enhanced arterial stiffness. Arterial function may change over time according to treatment, but the prognostic value of these changes has not been investigated.

objectivesThe aim of the present study was to assess whether an improvement in large artery rigidity in response to treatment, could predict a more favorable prognosis in a population of men with CAD.

methodsA total of 161 men with CAD (mean age 56.8 ± 10.9 years) being treated with conventional therapy underwent brachial-ankle pulse wave velocity (PWVba) measurements at baseline and after six months. Follow-up period was 3.5 years. End-points were major adverse cardiac events (MACE): acute myocardial infarction, unstable angina, coronary intervention, or cardiac death.

resultsDuring the three-year follow-up period (since initial six-month follow-up), 30 patients experienced MACE. After six-month follow-up, PWVba had not improved (ΔPWVba ≥ 0%, relative to baseline) in 85 (52.8%) of 161 men (Group 1), whereas it had improved (ΔPWVba < 0%) in the remaining 76 men (47.2%) (Group 2). During follow-up, we noticed 24 cardiovascular events in Group 1 and six events in Group 2 (P < 0.001). Cox proportional hazards analyses demonstrated that independent of conventional risk factor changes, absence of PWVba decrease was a predictor of MACE (RR 3.99; 95% CI:1.81-8.78; P = 0.004). The sensitivity of ΔPWVba was 80% and its specificity was 54%.

conclusionsThis study demonstrates that an improvement in arterial stiffness may be obtained after six months of conventional therapy and clearly identifies patients who have a more favorable prognosis.

Indexed as

AdultAgedAnkleArteriesBrachial ArteryCoronary Artery DiseaseFollow-Up StudiesHumansMaleMiddle AgedPrognosisProportional Hazards ModelsPulsatile FlowRisk FactorsSurveys and QuestionnairesVascular ResistanceVasodilator Agentsarterial stiffnesscoronary artery diseaseprognosis

Identifiers

PMID21127698
PMCPMC2988619

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.